Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Other disposition Director disposed of 58,476 shares (other)
  8. 4 Open-market sale Chief Scientific Officer sold 2,500 shares at $16.41 ($41,025)
  9. 4 Open-market sale Chief Scientific Officer sold 10,000 shares at an average $16.53 ($165,300)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale President and CEO sold 5,000 shares at an average $14.95 ($74,725)
  17. 4 Open-market sale President and CEO sold 5,000 shares at an average $15.42 ($77,100)
  18. 4 Open-market sale Chief Scientific Officer sold 12,500 shares at an average $13.93 ($174,075)
  19. 4 Open-market sale President and CEO sold 5,000 shares at an average $13.05 ($65,250)
  20. 4 Derivatives Options or other derivatives

Page 9 of 14 · 272 filings